236 related articles for article (PubMed ID: 18690919)
1. The clinical development of gamma-hydroxybutyrate (GHB).
Wedin GP; Hornfeldt CS; Ylitalo LM
Curr Drug Saf; 2006 Jan; 1(1):99-106. PubMed ID: 18690919
[TBL] [Abstract][Full Text] [Related]
2. The Xyrem risk management program.
Fuller DE; Hornfeldt CS; Kelloway JS; Stahl PJ; Anderson TF
Drug Saf; 2004; 27(5):293-306. PubMed ID: 15061684
[TBL] [Abstract][Full Text] [Related]
3. Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse.
Carter LP; Pardi D; Gorsline J; Griffiths RR
Drug Alcohol Depend; 2009 Sep; 104(1-2):1-10. PubMed ID: 19493637
[TBL] [Abstract][Full Text] [Related]
4. From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy.
Fuller DE; Hornfeldt CS
Pharmacotherapy; 2003 Sep; 23(9):1205-9. PubMed ID: 14524654
[TBL] [Abstract][Full Text] [Related]
5. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence.
Galloway GP; Frederick SL; Staggers FE; Gonzales M; Stalcup SA; Smith DE
Addiction; 1997 Jan; 92(1):89-96. PubMed ID: 9060200
[TBL] [Abstract][Full Text] [Related]
6. Gamma hydroxy butyrate abuse and dependency.
Gonzalez A; Nutt DJ
J Psychopharmacol; 2005 Mar; 19(2):195-204. PubMed ID: 15871147
[TBL] [Abstract][Full Text] [Related]
7. Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion.
Wang YG; Swick TJ; Carter LP; Thorpy MJ; Benowitz NL
J Clin Sleep Med; 2009 Aug; 5(4):365-71. PubMed ID: 19968016
[TBL] [Abstract][Full Text] [Related]
8. Sodium oxybate: a review of its use in the management of narcolepsy.
Robinson DM; Keating GM
CNS Drugs; 2007; 21(4):337-54. PubMed ID: 17381187
[TBL] [Abstract][Full Text] [Related]
9. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.
Busardò FP; Jones AW
Curr Neuropharmacol; 2015 Jan; 13(1):47-70. PubMed ID: 26074743
[TBL] [Abstract][Full Text] [Related]
10. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G
Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048
[TBL] [Abstract][Full Text] [Related]
11. Sodium oxybate (GHB) for treatment of cataplexy.
Borgen LA; Cook HN; Hornfeldt CS; Fuller DE
Pharmacotherapy; 2002 Jun; 22(6):798-9; discussion 799. PubMed ID: 12066974
[No Abstract] [Full Text] [Related]
12. [Gamma-hydroxybutyrate--a neurotransmitter, medicine, and drug].
Trendelenburg G; Ströhle A
Nervenarzt; 2005 Jul; 76(7):832, 834-8. PubMed ID: 15580464
[TBL] [Abstract][Full Text] [Related]
13. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4654-63. PubMed ID: 26698265
[TBL] [Abstract][Full Text] [Related]
14. The gamma-hydroxybutyrate withdrawal syndrome.
Tarabar AF; Nelson LS
Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
[TBL] [Abstract][Full Text] [Related]
15. gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness.
Pardi D; Black J
CNS Drugs; 2006; 20(12):993-1018. PubMed ID: 17140279
[TBL] [Abstract][Full Text] [Related]
16. Three deaths associated with use of Xyrem.
Zvosec DL; Smith SW; Hall BJ
Sleep Med; 2009 Apr; 10(4):490-3. PubMed ID: 19269893
[TBL] [Abstract][Full Text] [Related]
17. The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms.
J Toxicol Clin Toxicol; 2003; 41(2):131-5. PubMed ID: 12733850
[TBL] [Abstract][Full Text] [Related]
18. The distribution of gamma-hydroxybutyrate-induced Fos expression in rat brain: comparison with baclofen.
van Nieuwenhuijzen PS; McGregor IS; Hunt GE
Neuroscience; 2009 Jan; 158(2):441-55. PubMed ID: 18996447
[TBL] [Abstract][Full Text] [Related]
19. Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups.
Brennan R; Van Hout MC
J Psychoactive Drugs; 2014; 46(3):243-51. PubMed ID: 25052883
[TBL] [Abstract][Full Text] [Related]
20. Gamma-hydroxybutyrate (GHB): a newer drug of abuse.
O'Connell T; Kaye L; Plosay JJ
Am Fam Physician; 2000 Dec; 62(11):2478-83. PubMed ID: 11130233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
